Studies on the oncogenic potential of epstein‐barr‐virus (EBV)‐infected B cells in aids‐related disorders

Silvio Roncella, Patrizia Caretto, Guido Forni, Giovanna Cutrona, Antimo Verde, Dunia Ramarli, Paola Francia Di Celle, Robin Foà, Mario Sessarego, Vito Pistoia, Manlio Ferrarini

Research output: Contribution to journalArticle

Abstract

Spontaneous lymphoblastoid cell lines (LCLs) were established from the peripheral blood of 10 human immunodeficiency virus (HIV)‐seropositive patients in order to investigate whether or not progression of the cells towards a malignant state could be traced. The LCLs studied displayed no differences in their surface phenotype, karyotype, and tumorigenicity in nude mice as compared with a wide panel of control LCLs. Furthermore, no c‐myc rearrangement could be detected in any of the LCLs. However, 4 of the 10 LCLs derived from HIV‐seropositive patients formed colonies in agar with a cloning efficiency of 0.1–0.9%. This percentage was much lower than that of a control neoplastic B cell line (50%), but consistently higher than that observed for a battery of spontaneous LCLs. The cells of a number of sublines that were derived from the agar colonies expressed new activation markers (CD10 and Bac‐I) but did not induce tumors in nude mice or display chromosomal abnormalities. These sublines might comprise cells that have progressed towards a more markedly transformed state.

Original languageEnglish
Pages (from-to)78-82
Number of pages5
JournalInternational Journal of Cancer
Volume44
Issue number1 S
DOIs
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Studies on the oncogenic potential of epstein‐barr‐virus (EBV)‐infected B cells in aids‐related disorders'. Together they form a unique fingerprint.

Cite this